{"id":53939,"date":"2023-02-15T13:06:30","date_gmt":"2023-02-15T12:06:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/"},"modified":"2023-02-15T13:06:30","modified_gmt":"2023-02-15T12:06:30","slug":"whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/","title":{"rendered":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;In January 2023, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.whyzehealth.com%2F&amp;esheet=53325537&amp;newsitemid=20230215005267&amp;lan=en-US&amp;anchor=WHYZE+Health+Ltd.&amp;index=1&amp;md5=b9873e7b97ccc1d1de4880dda99c3240\" rel=\"nofollow noopener\" shape=\"rect\">WHYZE Health Ltd.<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.galwayclinic.com%2F&amp;esheet=53325537&amp;newsitemid=20230215005267&amp;lan=en-US&amp;anchor=Blackrock+Health+Galway+Clinic&amp;index=2&amp;md5=65cd575a4227b8f9015aabc6cd5fd55e\" rel=\"nofollow noopener\" shape=\"rect\">Blackrock Health Galway Clinic<\/a> began a pilot study of WHYZE Health\u2019s platform. \u201c<!-- no quote -->WHYZE and Blackrock Health Galway Clinic are working together to demonstrate the real-world evidence (RWE) power of patient-reported outcomes \u2026 to improve health outcomes and quality of care,\u201d said WHYZE Health CEO Frances Abeton.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/5\/7FrankOSullivanSurvey.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714077\/5\/Whyze_Health_Logo_CMYK.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714077\/21\/Whyze_Health_Logo_CMYK.jpg\"><\/a><\/p>\n<p>\nThrough RWE, the WHYZE Health Platform aids the delivery of informed prostate cancer treatment plans. Using patients\u2019 health data, test results, and patient-reported outcomes (PROMs), the platform aids physicians in selecting the treatment options that best meet their patient\u2019s needs. \u201c<!-- no quote -->The WHYZE Health portal will allow us to analyze these data systematically and in real-time and, for the first time, provide real-world outcome feedback to our patients and their care teams,\u201d explains Prof. Frank Sullivan, Clinical Director Radiation Oncology, Galway Clinic and Prostate Cancer Institute at University of Galway and CMO of WHYZE Health.\n<\/p>\n<p>\nThe WHYZE Health Platform tracks the patient\u2019s progress and collects relevant RWE throughout the entire health cycle of the patient\u2019s treatment plan, including follow-ups. It offers an intuitive, easy-to-use tool that gives patients more control over their course of care, taking into account individual risk factors and desired outcomes for each patient. Providers can share healthcare data with patients and allow online scheduling of upcoming appointments.\n<\/p>\n<p>\nThe WHYZE Health Platform drives a patient-centered transition to healthcare by bringing health and research opportunities directly to healthcare providers and patients, advancing global awareness of clinical trials, and enabling better health outcomes. Physicians use WHYZE Health data to streamline the care they provide, reduce diagnostic timelines, and improve patient outcomes. \u201c<!-- no quote -->Integration of digital technologies into our hospital services is key to the connection and communication with our patients and is the future of healthcare,\u201d said Evelyn Smyth, interim CEO of Galway Clinic.\n<\/p>\n<p>\nThe WHYZE Health pilot study is part of the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhih.ie%2Fhihi-open-call-winners%2F&amp;esheet=53325537&amp;newsitemid=20230215005267&amp;lan=en-US&amp;anchor=Health+Innovation+Hub+Ireland+Open+Call+2022&amp;index=3&amp;md5=bdca2f6ee4f73c4a1f2138bb84775812\" rel=\"nofollow noopener\" shape=\"rect\">Health Innovation Hub Ireland Open Call 2022<\/a>. The HIHI Open Call provides companies with the opportunity to work with healthcare organizations to show product efficacy and value in a live environment. These pilots highlight the benefits of novel solutions to patients, healthcare staff, and the healthcare system. In turn, successful pilots demonstrating value should be must-haves for modern patient-centered healthcare systems. \u201c<!-- no quote -->By giving patients more control over their care and streamlining treatment options for physicians,\u201d the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hih.ie%2F&amp;esheet=53325537&amp;newsitemid=20230215005267&amp;lan=en-US&amp;anchor=HIHI&amp;index=4&amp;md5=fb6f8167f460d213a7f31bee9934a3a9\" rel=\"nofollow noopener\" shape=\"rect\">HIHI<\/a> said, \u201c<!-- no quote -->the WHYZE Health Platform has the potential to improve health outcomes and advance the transition to patient-centered healthcare.\u201d\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nLindsey Langemeier<br \/>\n<br \/>SCORR Marketing<br \/>\n<br \/>402-405-4269<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x6c;&#x69;&#x6e;&#x64;&#x73;&#x65;&#x79;&#x40;&#x73;&#x63;&#x6f;&#x72;&#x72;&#x6d;&#x61;&#114;&#107;&#101;&#116;&#105;&#110;&#103;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#x69;&#x6e;&#100;&#115;ey&#x40;&#x73;&#x63;&#x6f;&#114;&#114;ma&#x72;&#x6b;&#x65;&#116;&#105;&#110;g&#46;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;In January 2023, WHYZE Health Ltd. and Blackrock Health Galway Clinic began a pilot study of WHYZE Health\u2019s platform. \u201cWHYZE and Blackrock Health Galway Clinic are working together to demonstrate the real-world evidence (RWE) power of patient-reported outcomes \u2026 to improve health outcomes and quality of care,\u201d said WHYZE Health CEO Frances Abeton. Through &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53939","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;In January 2023, WHYZE Health Ltd. and Blackrock Health Galway Clinic began a pilot study of WHYZE Health\u2019s platform. \u201cWHYZE and Blackrock Health Galway Clinic are working together to demonstrate the real-world evidence (RWE) power of patient-reported outcomes \u2026 to improve health outcomes and quality of care,\u201d said WHYZE Health CEO Frances Abeton. Through ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-15T12:06:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform\",\"datePublished\":\"2023-02-15T12:06:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/\"},\"wordCount\":429,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005267\\\/en\\\/1714078\\\/21\\\/7FrankOSullivanSurvey.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/\",\"name\":\"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005267\\\/en\\\/1714078\\\/21\\\/7FrankOSullivanSurvey.jpg\",\"datePublished\":\"2023-02-15T12:06:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005267\\\/en\\\/1714078\\\/21\\\/7FrankOSullivanSurvey.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005267\\\/en\\\/1714078\\\/21\\\/7FrankOSullivanSurvey.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/","og_locale":"en_US","og_type":"article","og_title":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;In January 2023, WHYZE Health Ltd. and Blackrock Health Galway Clinic began a pilot study of WHYZE Health\u2019s platform. \u201cWHYZE and Blackrock Health Galway Clinic are working together to demonstrate the real-world evidence (RWE) power of patient-reported outcomes \u2026 to improve health outcomes and quality of care,\u201d said WHYZE Health CEO Frances Abeton. Through ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-15T12:06:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform","datePublished":"2023-02-15T12:06:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/"},"wordCount":429,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/","url":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/","name":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg","datePublished":"2023-02-15T12:06:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230215005267\/en\/1714078\/21\/7FrankOSullivanSurvey.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/whyze-health-and-blackrock-health-galway-clinic-announce-pilot-study-of-whyze-health-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"WHYZE Health and Blackrock Health Galway Clinic Announce Pilot Study of WHYZE Health Platform"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53939"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53939\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}